<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37657964</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-307X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Trends in cognitive sciences</Title><ISOAbbreviation>Trends Cogn Sci</ISOAbbreviation></Journal><ArticleTitle>Effects of COVID-19 on cognition and brain health.</ArticleTitle><Pagination><StartPage>1053</StartPage><EndPage>1067</EndPage><MedlinePgn>1053-1067</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tics.2023.08.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1364-6613(23)00204-8</ELocationID><Abstract><AbstractText>COVID-19 is associated with a range of neurological, cognitive, and mental health symptoms both acutely and chronically that can persist for many months after infection in people with long-COVID syndrome. Investigations of cognitive function and neuroimaging have begun to elucidate the nature of some of these symptoms. They reveal that, although cognitive deficits may be related to brain imaging abnormalities in some people, symptoms can also occur in the absence of objective cognitive deficits or neuroimaging changes. Furthermore, cognitive impairment may be detected even in asymptomatic individuals. We consider the evidence regarding symptoms, cognitive deficits, and neuroimaging, as well as their possible underlying mechanisms.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Sijia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Experimental Psychology, University of Oxford, Oxford OX2 6GG, UK. Electronic address: sijia.zhao@psy.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toniolo</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK; Wellcome Trust Centre for Integrative Neuroimaging, Department of Experimental Psychology, University of Oxford, Oxford OX2 6AE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hampshire</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Brain Sciences, Imperial College London, 926 Sir Michael Uren Hub, 86 Wood Lane, London W12 0BZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Husain</LastName><ForeName>Masud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Experimental Psychology, University of Oxford, Oxford OX2 6GG, UK; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK; Wellcome Trust Centre for Integrative Neuroimaging, Department of Experimental Psychology, University of Oxford, Oxford OX2 6AE, UK. Electronic address: masud.husain@ndcn.ox.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trends Cogn Sci</MedlineTA><NlmUniqueID>9708669</NlmUniqueID><ISSNLinking>1364-6613</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FDG PET</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neuroimaging</Keyword><Keyword MajorTopicYN="N">neuropsychology</Keyword><Keyword MajorTopicYN="N">post-COVID condition</Keyword></KeywordList><CoiStatement>Declaration of interests No interests are declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>2</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>21</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37657964</ArticleId><ArticleId IdType="pmc">PMC10789620</ArticleId><ArticleId IdType="doi">10.1016/j.tics.2023.08.008</ArticleId><ArticleId IdType="pii">S1364-6613(23)00204-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Helms J., et al. Neurologic features in severe SARS-CoV-2 infection. N. Engl. J. Med. 2020;382:2268&#x2013;2270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul M.A., et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A., et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7:875&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., et al. 6-Month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison P.J., Taquet M. Neuropsychiatric disorders following SARS-CoV-2 infection. Brain. 2023:2241&#x2013;2247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10232232</ArticleId><ArticleId IdType="pubmed">36729559</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V., et al. COVID-19 and risk for mental disorders among adults in Denmark. JAMA Psychiatry. 2023;80:778&#x2013;786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10209831</ArticleId><ArticleId IdType="pubmed">37223890</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift A.K., et al. Neuropsychiatric ramifications of severe COVID-19 and other severe acute respiratory infections. JAMA Psychiatry. 2022;79:690&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9096686</ArticleId><ArticleId IdType="pubmed">35544272</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9:815&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., et al. Long-term neurologic outcomes of COVID-19. Nat. Med. 2022;28:2406&#x2013;2415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney L.L., et al. The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine. 2023;55</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao L., et al. Was the rate of long Covid as high as 45% &#x2013; a scary report with flaw. eClinicalMedicine. 2023;59</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10139873</ArticleId><ArticleId IdType="pubmed">37125399</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney L.L., et al. Response to &#x2018;Was the rate of long Covid as high as 45% &#x2013; a scary report with flaw&#x2019;. eClinicalMedicine. 2023;59</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10130600</ArticleId><ArticleId IdType="pubmed">37125400</ArticleId></ArticleIdList></Reference><Reference><Citation>Atchison C.J., et al. Long-term physical and mental health impact of COVID-19 on adults in England: follow up of a large random community sample. medRxiv. 2023 Published online April 24, 2023. https://doi.org/10.1101/2023.04.24.23289043.</Citation></Reference><Reference><Citation>Liu T.C., et al. Perceived cognitive deficits in patients with symptomatic SARS-CoV-2 and their association with post-COVID-19 condition. JAMA Netw. Open. 2023;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715897</ArticleId><ArticleId IdType="pubmed">37145596</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made long Covid. Soc. Sci. Med. 2021;268</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . World Health Organization; 2021. A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021.</Citation></Reference><Reference><Citation>Thaweethai T., et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329:1934&#x2013;1946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Danesh V., et al. Symptom clusters seen in adult COVID-19 recovery clinic care seekers. J. Gen. Intern. Med. 2023;38:442&#x2013;449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9663188</ArticleId><ArticleId IdType="pubmed">36376627</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese J.T., et al. Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes. eBioMedicine. 2023;87</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;1615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Office for National Statistics . UK Office for National Statistics; 2023. Prevalence of Ongoing Symptoms Following Coronavirus (COVID-19) Infection in the UK.</Citation></Reference><Reference><Citation>Ziauddeen N., et al. Characteristics and impact of long Covid: findings from an online survey. PLoS One. 2022;17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L., et al. Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis. Alzheimers Dement. 2022;18:1047&#x2013;1066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>de Alc&#xe2;ntara I.J., et al. Cognitive deficits in the acute phase of COVID-19: a review and meta-analysis. J. Clin. Med. 2023;12:762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9917639</ArticleId><ArticleId IdType="pubmed">36769410</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-J&#xfa;nior J.W.L., et al. COVID-19 associated cognitive impairment: a systematic review. Cortex. 2022;152:77&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9014565</ArticleId><ArticleId IdType="pubmed">35537236</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchetti G., et al. Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study. J. Neurol. 2022;269:3400&#x2013;3412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8898558</ArticleId><ArticleId IdType="pubmed">35249144</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandharipande P.P., et al. Long-term cognitive impairment after critical illness. N. Engl. J. Med. 2013;369:1306&#x2013;1316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3922401</ArticleId><ArticleId IdType="pubmed">24088092</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V., et al. Neuropsychiatric and cognitive outcomes in patients 6 months after COVID-19 requiring hospitalization compared with matched control patients hospitalized for non-COVID-19 illness. JAMA Psychiatry. 2022;79:486&#x2013;497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8943626</ArticleId><ArticleId IdType="pubmed">35319743</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., et al. Cognitive deficits in people who have recovered from COVID-19. eClinicalMedicine. 2021;39</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021;76:399&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaud V., et al. Pattern of cognitive deficits in severe COVID-19. J. Neurol. Neurosurg. Psychiatry. 2020;92:567&#x2013;568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8053331</ArticleId><ArticleId IdType="pubmed">33219042</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo M.S., et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., et al. Rapid vigilance and episodic memory decrements in COVID-19 survivors. Brain Commun. 2022;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8807287</ArticleId><ArticleId IdType="pubmed">35128398</ArticleId></ArticleIdList></Reference><Reference><Citation>Baseler H.A., et al. The negative impact of COVID-19 on working memory revealed using a rapid online quiz. PLoS One. 2022;17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9662713</ArticleId><ArticleId IdType="pubmed">36374838</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-S&#xe1;nchez C., et al. Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain Behav. 2022;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8933779</ArticleId><ArticleId IdType="pubmed">35137561</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza M., et al. Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints. Front. Aging Neurosci. 2022;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9631485</ArticleId><ArticleId IdType="pubmed">36337708</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C., et al. Cognitive dysfunction associated with COVID-19: a comprehensive neuropsychological study. J. Psychiatr. Res. 2022;150:40&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8943429</ArticleId><ArticleId IdType="pubmed">35349797</ArticleId></ArticleIdList></Reference><Reference><Citation>Azcue N., et al. Brain fog of post-COVID-19 condition and chronic fatigue syndrome, same medical disorder? J. Transl. Med. 2022;20:569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9724286</ArticleId><ArticleId IdType="pubmed">36474290</ArticleId></ArticleIdList></Reference><Reference><Citation>Albu S., et al. Multidisciplinary outpatient rehabilitation of physical and neurological sequelae and persistent symptoms of covid-19: a prospective, observational cohort study. Disabil. Rehabil. 2022;44:6833&#x2013;6840.</Citation><ArticleIdList><ArticleId IdType="pubmed">34559592</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P., et al. COVCOG 2: cognitive and memory deficits in long COVID: a second publication from the COVID and Cognition Study. Front. Aging Neurosci. 2022;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8967943</ArticleId><ArticleId IdType="pubmed">35370620</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando S.J., et al. Neuropsychological, medical, and psychiatric findings after recovery from acute COVID-19: a cross-sectional study. J. Acad. Consult. Liaison Psychiatry. 2022;63:474&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786396</ArticleId><ArticleId IdType="pubmed">35085824</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci R., et al. Long-lasting cognitive abnormalities after COVID-19. Brain Sci. 2021;11:235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7917789</ArticleId><ArticleId IdType="pubmed">33668456</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheetham N.J., et al. The effects of COVID-19 on cognitive performance in a community-based cohort: a COVID symptom study biobank prospective cohort study. eClinicalMedicine. 2023;62</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10466229</ArticleId><ArticleId IdType="pubmed">37654669</ArticleId></ArticleIdList></Reference><Reference><Citation>Pihlaja R.E., et al. Associations of subjective and objective cognitive functioning after COVID-19: a six-month follow-up of ICU, ward, and home-isolated patients. Brain Behav. Immun. Health. 2023;27</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9812472</ArticleId><ArticleId IdType="pubmed">36624888</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhakaran D., et al. Neurophenotypes of COVID-19: risk factors and recovery outcomes. Brain Behav. Immun. Health. 2023;30</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10239310</ArticleId><ArticleId IdType="pubmed">37293441</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker J.H., et al. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw. Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti S., et al. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life. Eur. Arch. Psychiatry Clin. Neurosci. 2022;272:773&#x2013;782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8546751</ArticleId><ArticleId IdType="pubmed">34698871</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T., et al. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ. 2023;381</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K., et al. Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur. Neuropsychopharmacol. 2021;46:39&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Dressing A., et al. Neuropsychologic profiles and cerebral glucose metabolism in neurocognitive long COVID syndrome. J. Nucl. Med. 2022;63:1058&#x2013;1063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9258569</ArticleId><ArticleId IdType="pubmed">34649946</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattioli F., et al. Neurological and cognitive sequelae of Covid-19: a four month follow-up. J. Neurol. 2021;268:4422&#x2013;4428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8088203</ArticleId><ArticleId IdType="pubmed">33932157</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown L.A., et al. The unique contribution of depression to cognitive impairment in post-acute sequelae of SARS-CoV-2 infection. Brain Behav. Immun. Health. 2022;22</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983478</ArticleId><ArticleId IdType="pubmed">35403066</ArticleId></ArticleIdList></Reference><Reference><Citation>Diana L., et al. Monitoring cognitive and psychological alterations in COVID-19 patients: a longitudinal neuropsychological study. J. Neurol. Sci. 2023;444</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9707027</ArticleId><ArticleId IdType="pubmed">36473347</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., et al. Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort. eClinicalMedicine. 2022;47</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9048584</ArticleId><ArticleId IdType="pubmed">35505938</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., et al. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E., et al. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. 2022;328:676&#x2013;678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. eClinicalMedicine. 2022;53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case&#x2013;control study. Lancet Infect. Dis. 2022;22:43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W.-Q., et al. The role of depression and anxiety in the relationship between poor sleep quality and subjective cognitive decline in Chinese elderly: exploring parallel, serial, and moderated mediation. J. Affect. Disord. 2021;294:464&#x2013;471.</Citation><ArticleIdList><ArticleId IdType="pubmed">34325166</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., et al. Anxiety, depression and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: a multicenter study. J. Infect. 2021;83:496&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236125</ArticleId><ArticleId IdType="pubmed">34192525</ArticleId></ArticleIdList></Reference><Reference><Citation>Cysique L.A., et al. The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC. Ann. Clin. Transl. Neurol. 2023;10:1338&#x2013;1352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10424655</ArticleId><ArticleId IdType="pubmed">37318955</ArticleId></ArticleIdList></Reference><Reference><Citation>Cockshell S.J., Mathias J.L. Cognitive functioning in chronic fatigue syndrome: a meta-analysis. Psychol. Med. 2010;40:1253&#x2013;1267.</Citation><ArticleIdList><ArticleId IdType="pubmed">20047703</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin E., et al. Brain imaging of patients with COVID-19: findings at an academic institution during the height of the outbreak in New York City. AJNR Am. J. Neuroradiol. 2020;41:2001&#x2013;2008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7658823</ArticleId><ArticleId IdType="pubmed">32819899</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson R.W., et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain J. Neurol. 2020;143:3104&#x2013;3120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano G.S., et al. Acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalitis following COVID-19: systematic review and meta-synthesis. Neurol. Neuroimmunol. Neuroinflamm. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8404207</ArticleId><ArticleId IdType="pubmed">34452974</ArticleId></ArticleIdList></Reference><Reference><Citation>Caroli A., et al. Brain diffusion alterations in patients with COVID-19 pathology and neurological manifestations. NeuroImage Clin. 2023;37</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9883079</ArticleId><ArticleId IdType="pubmed">36731251</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim P.H., et al. Neuroimaging findings in patients with COVID-19: a systematic review and meta-analysis. Korean J. Radiol. 2021;22:1875&#x2013;1885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8546134</ArticleId><ArticleId IdType="pubmed">34269530</ArticleId></ArticleIdList></Reference><Reference><Citation>Rau A., et al. Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms. Brain J. Neurol. 2022;145:3203&#x2013;3213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214163</ArticleId><ArticleId IdType="pubmed">35675908</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. eClinicalMedicine. 2021;31</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez-Cirarda M., et al. Multimodal neuroimaging in post-COVID syndrome and correlation with cognition. Brain J. Neurol. 2023;146:2142&#x2013;2152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9620345</ArticleId><ArticleId IdType="pubmed">36288544</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., et al. Persistent white matter changes in recovered COVID-19 patients at the 1-year follow-up. Brain. 2022;145:1830&#x2013;1838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8754808</ArticleId><ArticleId IdType="pubmed">34918020</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez-Cirarda M., et al. Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome. eBioMedicine. 2023;94</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10366393</ArticleId><ArticleId IdType="pubmed">37453364</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti F., et al. Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: a multimodal magnetic resonance imaging study. Brain Behav. Immun. Health. 2021;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8562046</ArticleId><ArticleId IdType="pubmed">34746876</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp J.A., et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;144:1263&#x2013;1276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kas A., et al. The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2543&#x2013;2557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7810428</ArticleId><ArticleId IdType="pubmed">33452633</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazhenets G., et al. Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J. Nucl. Med. 2021;62:910&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8882885</ArticleId><ArticleId IdType="pubmed">33789937</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini A.L., et al. Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients. Eur. J. Nucl. Med. Mol. Imaging. 2022;50:90&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388976</ArticleId><ArticleId IdType="pubmed">35984451</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer P.T., et al. Molecular imaging findings on acute and long-term effects of COVID-19 on the brain: a systematic review. J. Nucl. Med. 2022;63:971&#x2013;980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9258567</ArticleId><ArticleId IdType="pubmed">35177424</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., et al. Long COVID hallmarks on [18F]FDG-PET/CT: a case&#x2013;control study. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:3187&#x2013;3197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2823&#x2013;2833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Morand A., et al. Similar patterns of [18F]-FDG brain PET hypometabolism in paediatric and adult patients with long COVID: a paediatric case series. Eur. J. Nucl. Med. Mol. Imaging. 2022;49:913&#x2013;920.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8376118</ArticleId><ArticleId IdType="pubmed">34414470</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo S., et al. Dementia and COVID-19, a bidirectional liaison: risk factors, biomarkers, and optimal health care. J. Alzheimers Dis. JAD. 2021;82:883&#x2013;898.</Citation><ArticleIdList><ArticleId IdType="pubmed">34092646</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo S., et al. Is the frontal lobe the primary target of SARS-CoV-2? J. Alzheimers Dis. 2021;81:75&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">33720900</ArticleId></ArticleIdList></Reference><Reference><Citation>Furlanis G., et al. Cognitive deficit in post-acute COVID-19: an opportunity for EEG evaluation? Neurol. Sci. 2023;44:1491&#x2013;1498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9902820</ArticleId><ArticleId IdType="pubmed">36749529</ArticleId></ArticleIdList></Reference><Reference><Citation>Antony A.R., Haneef Z. Systematic review of EEG findings in 617 patients diagnosed with COVID-19. Seizure. 2020;83:234&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7569418</ArticleId><ArticleId IdType="pubmed">33121875</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota T., et al. Meta-analysis of EEG findings in patients with COVID-19. Epilepsy Behav. 2021;115</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833461</ArticleId><ArticleId IdType="pubmed">33342709</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., et al. Electroencephalographic abnormalities are common in COVID-19 and are associated with outcomes. Ann. Neurol. 2021;89:872&#x2013;883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8104061</ArticleId><ArticleId IdType="pubmed">33704826</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidbauer M.L., et al. COVID-19 and intracranial hemorrhage: a multicenter case series, systematic review and pooled analysis. J. Clin. Med. 2022;11:605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8836638</ArticleId><ArticleId IdType="pubmed">35160057</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen-Kondering U., et al. Patterns of acute ischemic stroke and intracranial hemorrhage in patients with COVID-19: results of a retrospective multicenter neuroimaging-based study from three central European countries. J. Neurol. 2023;270:2349&#x2013;2359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9947908</ArticleId><ArticleId IdType="pubmed">36820915</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon L., et al. Cerebral microhaemorrhage in COVID-19: a critical illness related phenomenon? Stroke Vasc. Neurol. 2020;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7681795</ArticleId><ArticleId IdType="pubmed">33208493</ArticleId></ArticleIdList></Reference><Reference><Citation>Toeback J., et al. Microbleed patterns in critical illness and COVID-19. Clin. Neurol. Neurosurg. 2021;203</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7939996</ArticleId><ArticleId IdType="pubmed">33735661</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahammedi A., et al. Imaging of neurologic disease in hospitalized patients with COVID-19: an Italian multicenter retrospective observational study. Radiology. 2020;297:E270&#x2013;E273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7587295</ArticleId><ArticleId IdType="pubmed">32437313</ArticleId></ArticleIdList></Reference><Reference><Citation>Radmanesh A., et al. Brain imaging use and findings in COVID-19: a single academic center experience in the epicenter of disease in the United States. Am. J. Neuroradiol. 2020;41:1179&#x2013;1183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7357666</ArticleId><ArticleId IdType="pubmed">32467191</ArticleId></ArticleIdList></Reference><Reference><Citation>Klironomos S., et al. Nervous system involvement in coronavirus disease 2019: results from a retrospective consecutive neuroimaging cohort. Radiology. 2020;297:E324&#x2013;E334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7393954</ArticleId><ArticleId IdType="pubmed">32729812</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.-H., et al. Microvascular injury in the brains of patients with Covid-19. N. Engl. J. Med. 2021;384:481&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo J., et al. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax. 2021;76:412&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pubmed">33408195</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini M., et al. How COVID-19 affects the brain. JAMA Psychiatry. 2021;78:682&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosentino G., et al. Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: a critical systematic review. Eur. J. Neurol. 2021;28:3856&#x2013;3865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444743</ArticleId><ArticleId IdType="pubmed">34339563</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar S., et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J. Neuroinflammation. 2020;17:231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7406702</ArticleId><ArticleId IdType="pubmed">32758257</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajnzylber J., et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat. Commun. 2020;11:5493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7603483</ArticleId><ArticleId IdType="pubmed">33127906</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Pensato U., et al. Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy. Ann. Clin. Transl. Neurol. 2021;8:968&#x2013;979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8045903</ArticleId><ArticleId IdType="pubmed">33780166</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A., et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;2468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Soung A.L., et al. COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis. Brain. 2022;145:4193&#x2013;4201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9452175</ArticleId><ArticleId IdType="pubmed">36004663</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga J., et al. Neuroinflammation after COVID-19 with persistent depressive and cognitive symptoms. JAMA Psychiatry. 2023;80:787&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10233457</ArticleId><ArticleId IdType="pubmed">37256580</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., et al. Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia. Alzheimers Dement. 2022;18:899&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9011610</ArticleId><ArticleId IdType="pubmed">35023610</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham E.J., et al. Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses. Brain. 2022;145:4097&#x2013;4107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494359</ArticleId><ArticleId IdType="pubmed">36065116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N., et al. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. eBioMedicine. 2021;70</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8320425</ArticleId><ArticleId IdType="pubmed">34333238</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C.B., et al. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 2022;23:3&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021;24:168&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Placantonakis D.G., et al. SARS-CoV-2 is no detected in the cerebrospinal fluid of encephalopathic COVID-19 patients. Front. Neurol. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7759491</ArticleId><ArticleId IdType="pubmed">33362695</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis A., et al. Cerebrospinal fluid from COVID-19 patients with olfactory/gustatory dysfunction: a review. Clin. Neurol. Neurosurg. 2021;207</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8196517</ArticleId><ArticleId IdType="pubmed">34146842</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur K.T., et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain. 2021;144:2696&#x2013;2708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083258</ArticleId><ArticleId IdType="pubmed">33856027</ArticleId></ArticleIdList></Reference><Reference><Citation>Guthrie E., Nayak A. In: Seminars in Liaison Psychiatry. 2nd edn. Guthrie E., et al., editors. Royal College of Psychiatrists; 2012. Psychological reaction to physical illness; pp. 51&#x2013;65.</Citation></Reference><Reference><Citation>Castaneda A.E., et al. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J. Affect. Disord. 2008;106:1&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">17707915</ArticleId></ArticleIdList></Reference><Reference><Citation>Re&#x2019;em Y., et al. Factors associated with psychiatric outcomes and coping in long COVID. Nat. Ment. Health. 2023;1:361&#x2013;372.</Citation></Reference><Reference><Citation>Ortelli P., et al. Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: insights into a challenging symptom. J. Neurol. Sci. 2021;420</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834526</ArticleId><ArticleId IdType="pubmed">33359928</ArticleId></ArticleIdList></Reference><Reference><Citation>Vannorsdall T.D., et al. Cognitive dysfunction, psychiatric distress, and functional decline after COVID-19. J. Acad. Consult. Liaison Psychiatry. 2022;63:133&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8591857</ArticleId><ArticleId IdType="pubmed">34793996</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J.G., et al. Cognitive impairments in patients with subacute coronavirus disease: initial experiences in a post-coronavirus disease clinic. Front. Aging Neurosci. 2022;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9681802</ArticleId><ArticleId IdType="pubmed">36437985</ArticleId></ArticleIdList></Reference><Reference><Citation>Ak&#x131;nc&#x131; B., et al. Evaluation of cognitive functions in adult individuals with COVID-19. Neurol. Sci. 2022;44:793&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9793347</ArticleId><ArticleId IdType="pubmed">36574178</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., et al. The landscape of cognitive function in recovered COVID-19 patients. J. Psychiatr. Res. 2020;129:98&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzhdii N., Barantcevich E. Analysis of post-COVID-19 cognitive functioning in young people with type 1 diabetes mellitus. Eur. Neuropsychopharmacol. 2021;53:S379.</Citation></Reference><Reference><Citation>Alemanno F., et al. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: a COVID-rehabilitation unit experience. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7870071</ArticleId><ArticleId IdType="pubmed">33556127</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez R., et al. Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors. J. Intern. Med. 2021;290:621&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013333</ArticleId><ArticleId IdType="pubmed">33533521</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen E.L., et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg City Health Study COVID programme. Eur. Heart J. 2022;43:1124&#x2013;1137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.-H., et al. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol. 2022;79:509&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto O.H., et al. Cognitive sequelae of long COVID may not be permanent: a prospective study. Eur. J. Neurol. 2022;29:1218&#x2013;1221.</Citation><ArticleIdList><ArticleId IdType="pubmed">34918425</ArticleId></ArticleIdList></Reference><Reference><Citation>Voruz P., et al. Long COVID neuropsychological deficits after severe, moderate or mild infection. Clin. Trans. Neurosci. 2021;6:9.</Citation></Reference><Reference><Citation>Herrera E., et al. Cognitive impairment in young adults with post COVID-19 syndrome. Sci. Rep. 2023;13:6378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10113715</ArticleId><ArticleId IdType="pubmed">37076533</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . World Health Organization; 2023. A Clinical Case Definition for Post COVID-19 Condition in Children and Adolescents by Expert Consensus, 16 February 2023.</Citation></Reference><Reference><Citation>Dattner I., et al. The role of children in the spread of COVID-19: using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children. PLoS Comput. Biol. 2021;17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877572</ArticleId><ArticleId IdType="pubmed">33571188</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohn B., et al. Incidence of dementia following hospitalization with infection among adults in the Atherosclerosis Risk in Communities (ARIC) Study cohort. JAMA Netw. Open. 2023;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9857407</ArticleId><ArticleId IdType="pubmed">36622673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranger T.A., et al. Preexisting neuropsychiatric conditions and associated risk of severe COVID-19 infection and other acute respiratory infections. JAMA Psychiatry. 2023;80:57&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9647578</ArticleId><ArticleId IdType="pubmed">36350602</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., et al. COVID-19 and dementia: analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimers Dement. 2021;17:1297&#x2013;1306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014535</ArticleId><ArticleId IdType="pubmed">33559975</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N., et al. The impact of dementia on the clinical outcome of COVID-19: a systematic review and meta-analysis. J. Alzheimers Dis. 2020;78:1775&#x2013;1782.</Citation><ArticleIdList><ArticleId IdType="pubmed">33285638</ArticleId></ArticleIdList></Reference><Reference><Citation>Canas L.S., et al. Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations. Lancet Digit. Health. 2023;5:e421&#x2013;e434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10187990</ArticleId><ArticleId IdType="pubmed">37202336</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>